Canaccord Genuity Group Issues Pessimistic Forecast for Zimmer Biomet (NYSE:ZBH) Stock Price
Zimmer Biomet (NYSE:ZBH – Get Free Report) had its price objective dropped by equities researchers at Canaccord Genuity Group from $115.00 to $101.00 in a report released on Monday,Benzinga reports. The firm currently has a “hold” rating on the medical equipment provider’s stock. Canaccord Genuity Group’s price objective suggests a potential upside of 3.78% from […]
Zimmer Biomet (NYSE:ZBH – Get Free Report) had its price objective dropped by equities researchers at Canaccord Genuity Group from $115.00 to $101.00 in a report released on Monday,Benzinga reports. The firm currently has a “hold” rating on the medical equipment provider’s stock. Canaccord Genuity Group’s price objective suggests a potential upside of 3.78% from […]
